For the first time, the usage of the CADScor® System in a high prevalence cohort is described by M. Renker et al. This prospective randomized cohort was designed as technical study to confirm predicted sensitivity and specificity in a high prevalence patient group (not the intended patient group for the CADScor®System in clinical practice). Use of the CADScor®System allowed the identification of individuals with CAD in a high-prevalence cohort with a high sensitivity of 97.6% but with a lower specificity. The negative predictive value of 90.5% was within the predicted range for a high-prevalence cohort. The results were intended to be presented during the annual meeting of the German cardiac society and are published as poster abstract.
Poster Abstract>>https://www.abstractserver.com/dgk2020/jt/abstracts/P1850.htm